Ergoteles’s Cartesian Therapeutics RNAC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q3
Sell
-12,200
Closed -$479K 1920
2022
Q2
$479K Buy
+12,200
New +$479K 0.01% 855